Juvéderm ULTRA: Next-Generation Dermal Filler Containing Lidocaine Now Available in Europe

PARIS, Jan. 10, 2008 – Today at the International Master Course on Aging Skin (IMCAS), Allergan, the makers of BOTOX®/VISTABEL®/VISTABEX® (botulinum toxin type A, announced the launch of Juvéderm® ULTRA for the treatment of facial wrinkles and folds. Juvéderm® ULTRA is a hyaluronic acid dermal filler containing lidocaine, an anaesthetic that allows for a gentle injection experience. According to preliminary results from a study of 60 women released at IMCAS, 81% of people who received Juvederm® ULTRA felt only slight or no discomfort at all.